The Skinny on Fatty Acid-Binding Protein**Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 50, Issue 21, 2007, Pages 2068-2070

  de Lemos, James A ^a   O'Donoghue, Michelle ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN; FIBRINOGEN RECEPTOR ANTAGONIST; LOW MOLECULAR WEIGHT HEPARIN; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; EDITORIAL; HEART MUSCLE NECROSIS; HUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; FATTY ACID-BINDING PROTEINS; HUMANS; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

EID: 36049041247     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.07.072     Document Type: Editorial

References (16)

1. Morrow D.A., Cannon C.P., Jesse R.L., et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 115 (2007) e356-e375
2. Alcalai R., Planer D., Culhaoglu A., Osman A., Pollak A., and Lotan C. Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. Arch Intern Med 167 (2007) 276-281
3. Kilcullen N., Viswanathan K., Das R., et al., EMMACE-2 Investigators. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J Am Coll Cardiol 50 (2007) 2061-2067
4. Tanaka T., Hirota Y., Sohmiya K., Nishimura S., and Kawamura K. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 24 (1991) 195-201
5. Kleine A.H., Glatz J.F., Van Nieuwenhoven F.A., and Van der Vusse G.J. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 116 (1992) 155-162
6. Glatz J.F., van der Vusse G.J., Simoons M.L., Kragten J.A., van Dieijen-Visser M.P., and Hermens W.T. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 272 (1998) 87-92
7. Okamoto F., Sohmiya K., Ohkaru Y., et al. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 38 (2000) 231-238
8. Seino Y., Ogata K., Takano T., et al. Use of a whole blood rapid panel test for heart-type fatty acid-binding protein in patients with acute chest pain: comparison with rapid troponin T and myoglobin tests. Am J Med 115 (2003) 185-190
9. Ishii J., Ozaki Y., Lu J., et al. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome. Clin Chem 51 (2005) 1397-1404
10. de Lemos J.A., Antman E.M., Morrow D.A., et al. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. Clin Chim Acta 298 (2000) 85-97
11. O'Donoghue M., de Lemos J.A., Morrow D.A., et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 114 (2006) 550-557
12. Morrow D.A., and de Lemos J.A. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 115 (2007) 949-952
13. Ishii J., Wang J.H., Naruse H., et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 43 (1997) 1372-1378
14. de Lemos J.A., Morrow D.A., Gibson C.M., et al. The prognostic value of serum myoglobin in patients with non-ST segment elevation acute coronary syndromes: Results from the TIMI 11B and TACTICS-TIMI 18 studies. J Am Coll Cardiol 40 (2002) 238-244
15. Nakata T., Hashimoto A., Hase M., Tsuchihashi K., and Shimamoto K. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 99 (2003) 96-104
16. Suzuki M., Hori S., Noma S., and Kobayashi K. Prognostic value of a qualitative test for heart-type fatty acid-binding protein in patients with acute coronary syndrome. Int Heart J 46 (2005) 601-606